An interventional study of interview with advanced practice nurse in Virus-HIV, sponsored by Centre Hospitalier Universitaire de Nice. Suspended at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Centre Hospitalier Universitaire de Nice · Not applicable, Interventional, and Other
Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old. This population is exposed to high multimorbidity, leading to frequent polypharmacy, defined as the regular use of at least five medications. Polypharmacy also has a qualitative dimension, including potentially inappropriate prescriptions. It increases the risk of adverse effects and drug interactions and impairs quality of life. A coordinated geriatric approach is therefore essential to optimize care. Healthy aging, promoted by the WHO, aims to improve the lives of older people. In this context, a study will be conducted at the Nice University Hospital among PLHIV aged 75 and over. It will collect quantitative data, the results of which will enable us to consider, if necessary, adapting the care pathways of these patients whose needs are complex.
2,040 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 272 are open to participants now.
This study's planned enrollment of 136 is above the median of 105 across 1,543 interventional studies indexed under Acquired Immunodeficiency Syndrome.
Browse Acquired Immunodeficiency Syndrome studies →Centre Hospitalier Universitaire de Nice is the lead sponsor of 709 studies on the registry; 176 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: interview with advanced practice nurse
45 to 60 minutes of interview
Describe polypharmacy among people living with HIV aged 75 and older.
The average number of medications taken
Time frame: 15 months
Assess the most common comorbidities associated with polypharmacy in the population of PLHIV aged 75
Number et type of comorbidities
Time frame: 15 months
Assess whether people taking multiple medications have a lower treatment adherence score than those taking fewer medications.
Score obtained on the Morisky MMAS-8 questionnaire
Time frame: 15 months
Assess the level of functional independence in this age group and link it to the existence of polypharmacy.
Lawton and Brody IADL scale
Time frame: 15 months
Plan to share: No
No publications or documents are linked to this record.
This study is suspended, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acquired Immunodeficiency Syndrome→
Centre Hospitalier Universitaire de Nice